Ginkgo Bioworks Holdings (DNA) Annual Income Statement (USD)
DNA Quarterly Financials (USD)
Frequently Asked Questions About Ginkgo Bioworks Holdings (DNA) Stock
Ginkgo Bioworks Holdings's (DNA) last reported annual revenue was USD 251.46 Million.
Ginkgo Bioworks Holdings's (DNA) annual revenue growth rate based on the revenue reported in the past 5 years is : 22.11%
Ginkgo Bioworks Holdings's(DNA) is not profitable as of its last reported annual financials.
The net profit margin for Ginkgo Bioworks Holdings's(DNA) from its laster reported year is -355.08%
The return on equity (ROE) for Ginkgo Bioworks Holdings's(DNA) from its last reported annual financials is : -63.02%
The return on assets (ROA) for Ginkgo Bioworks Holdings's(DNA) from its last reported annual financials is : -21.82%
The return on invested capital (ROIC) for Ginkgo Bioworks Holdings's(DNA) from its last reported annual financials is : -47.44%
The Debt to Equity ratio for Ginkgo Bioworks Holdings's(DNA) from its last reported annual financials is : 0.00%
The dividend yield for Ginkgo Bioworks Holdings's(DNA) from its laster reported year is 0.00%
Ginkgo Bioworks Holdings's(DNA) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for DNA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
